SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

FibroBiologics, Inc. Common Stock

FBLG XNAS
$0.70 -0.11 (-13.01%) ▼ 15-min delayed
Open
$0.87
High
$0.87
Low
$0.70
Volume
50.3K
Market Cap
$6.34M

About FibroBiologics, Inc. Common Stock

FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 15 Website →

Related Market News

No specific coverage for FBLG yet. Check out our latest market news or earnings calendar.

Get FBLG Alerts

Stay ahead with breaking news, price alerts, and expert analysis on FibroBiologics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.